B06AX Other hematological agents
ATC group of level 4 – chemical subgroup · in plain English: other medicines for the blood
This site has the patient leaflet or the SPC of 2 medicines in this group and its subgroups.
- 1 no longer supplied or not available
Active substance: Crizanlizumab – all medicines with this substance, also in combinations.
Place in the ATC classification
- B Blood and blood forming organ drugs 1,013 medicines
- B06 Other hematological agents 24 medicines
- B06A Other hematological agents 24 medicines
-
B06AX Other hematological agents 2 medicines
- B06AX01 crizanlizumab 1 medicine
- B06AX02 betibeglogene autotemcel 1 medicine
-
B06AX Other hematological agents 2 medicines
- B06A Other hematological agents 24 medicines
- B06 Other hematological agents 24 medicines
Medicines in the group and its subgroups
| Medicine | Legal category |
|---|---|
| Adakveo SPC no longer supplied (B06AX01 crizanlizumab) | – |
| Zynteglo 1.2-20 million Cells/ml Dispersion for infusion SPC (B06AX02 betibeglogene autotemcel) | – |
Other groups of the same level
- B06AA Enzymes, hematological 1 medicine
- B06AC Drugs used in hereditary angioedema 20 medicines
Other names of the ATC group
- German: B06AX Andere Hämatologika
- German: B06AX Andere Hämatologika
- Italian: B06AX Altri Agenti Ematologica
- Turkish: B06AX ATC'deki diğer hematolojik ajanlar
Sources
- Patient leaflets and SPCs: the MHRA product information (products.mhra.gov.uk) and the European Medicines Agency (EMA)
- Active substances, ATC codes and legal categories: the NHS Dictionary of Medicines and Devices (dm+d), NHS Business Services Authority
- World Health Organization (WHO): ATC/DDD classification, group B06AX
Contains public sector information licensed under the Open Government Licence v3.0.
Ask your doctor or pharmacist which medicine is right for you.